[vc_row][vc_column][vc_column_text][WP-Coder id="1"] [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] New research shows: Neurofeedback is an ‘Evidence-Based’ treatment for ADHD [/vc_column_text][vc_column_text el_class="maintext"]Nijmegen, July 16th 2009 – Neurofeedback – also called EEG Biofeedback – is a method used to train brain activity in order to normalize Brain function and treat psychiatric disorders. This treatment method has gained interest over the last 10 years, however the question whether this treatment should be regarded as an Evidence-Based treatment was unanswered until now. Tomorrow a study will be published in the scientific journal ‘Clinical EEG and Neuroscience’ demonstrating that Neurofeedback can indeed be regarded as an evidence-based treatment for Attention Deficit- /...
International Biomarker-Depression study: iSPOT-D
[vc_row][vc_column][vc_column_text][WP-Coder id="1"] [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] International Biomarker-Depression study: iSPOT-D [/vc_column_text][vc_column_text el_class="maintext"]Nijmegen, 26 March 2009 - Research shows that antidepressants only affect 40-60% of patients, while painkillers work for almost everyone. How is this possible? And above all, how can this be improved? To answer these questions, Brainclinics Diagnostics has started an international partnership with the largest Biomarker study in Depression ever conducted. In total, almost 3000 people will be examined for genetic material, brain activity and psychological variables. In the Netherlands this investigation will officially start on 1 April. The aim of this research is to arrive at biomarkers - indicators that...